2022 Fall Conference | LU3 - Leading a Team to a Strategic Decision

Date Friday 10/28/22

Time 01:00 PM - 02:30 PM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) David M. Greer, MD, FAAN

Topic(s) Leadership

Learning Objectives Participants should gain tools and frameworks for effective decision making, moving strategies forward, and accomplishing goals. Learn how leaders in health care organizations and neurology departments build consensus among stakeholders and their team by developing strategic plan documents. Participants will learn how to develop short-term and long-term goals, execute goals on a specific timeline, and the common traps of strategic thinking. A panel of neurology leaders will discuss concrete solutions and real-life scenarios, including what has worked and what hasn't worked for them. This program will not be available within the virtual platform.

CME Available 1.50 CME credits

Core Competencies Interpersonal and Communication Skills, Professionalism, Medical Knowledge

Program Level Intermediate

Recommended Audience Advanced Practice Provider, Business Administrator

Teaching Styles Case-based, Didactic, Interactive

Program Materials

Event Timeline
01:00 PM - 01:10 PM PDT	Speaker	Strategic Decision Making Theory and Definitions David M. Greer, MD, FAAN
01:10 PM - 02:00 PM PDT	Speaker	Panel Discussion David M. Greer, MD, FAAN, Thabele M. Leslie-Mazwi, MD, Salvador Cruz-Flores, MD, FAAN, Jana Pettit, MBA, Cathy A. Sila, MD, FAAN
02:00 PM - 02:30 PM PDT	Q&A	Questions and Answers David M. Greer, MD, FAAN, Thabele M. Leslie-Mazwi, MD, Salvador Cruz-Flores, MD, FAAN, Jana Pettit, MBA, Cathy A. Sila, MD, FAAN

Faculty Disclosures
David M. Greer, MD, FAAN	Dr. Greer has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Thieme, Inc. Dr. Greer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for multiple. An immediate family member of Dr. Greer has or had stock in Vertex Pharmaceuticals. The institution of Dr. Greer has received research support from NINDS. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has a non-compensated relationship as a Treasurer-Elect with American Neurological Association that is relevant to AAN interests or activities. Dr. Greer has a non-compensated relationship as a President with Neurocritical Care Society that is relevant to AAN interests or activities.
Thabele M. Leslie-Mazwi, MD	Dr. Leslie-Mazwi has a non-compensated relationship as a Board Member with American Brain Foundation that is relevant to AAN interests or activities. Dr. Leslie-Mazwi has a non-compensated relationship as a Council Member with American Heart Association/American Stroke Association that is relevant to AAN interests or activities.
Salvador Cruz-Flores, MD, FAAN	The institution of Dr. Cruz-Flores has received research support from University of Texas System.
Jana Pettit, MBA	Ms. Pettit has nothing to disclose.
Cathy A. Sila, MD, FAAN	Dr. Sila has nothing to disclose.

��ɫ��

��ɫ��